neuropsychopharmacology Research Articles

This shows a brain and a swirly background

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

Neuroscience NewsFebruary 2, 2020

A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered.... Read More...

Brain CancerFeaturedNeurosciencePsychology0 Comments 07 min read

This shows a psychedelic face and flowers

Could psychedelics help treat mental health and resolve the climate crisis?

Neuroscience NewsJanuary 28, 2020

Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility.... Read More...

FeaturedNeurosciencePsychology1 Comment 27 min read

This shows two heads and a swirly background

New research confirms lingering mood benefit of psychedelics

Neuroscience NewsJanuary 20, 2020

Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off. ... Read More...

FeaturedNeurosciencePsychology0 Comments 02 min read

This shows psychedelic swirls around a person's head

Psychedelic drugs could help treat PTSD

Neuroscience NewsJanuary 17, 2020

Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone.... Read More...

FeaturedNeurosciencePsychology0 Comments 03 min read

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Neuroscience NewsDecember 11, 2019

Researchers have distinguished two different molecular pathways responsible for addiction and the prosocial feelings generated by MDMA. The findings could lead to novel treatments for psychiatric disorders marked by withdrawal and social awkwardness.... Read More...

FeaturedNeurosciencePsychology0 Comments 09 min read

Common antidepressant may not reduce depression symptoms, but does reduce anxiety

Neuroscience NewsSeptember 20, 2019

Sertraline (Zoloft), a commonly prescribed SSRI antidepressant, may not be as effective at treating depression within 6 weeks as previously thought. However, the drug is effective for treating anxiety symptoms. ... Read More...

FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology0 Comments 08 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Neuroscience NewsSeptember 1, 2019

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.... Read More...

FeaturedNeurosciencePsychology0 Comments 06 min read

Ketamine isn’t an opioid and treats depression in a unique way

Neuroscience NewsJuly 31, 2019

A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment.... Read More...

FeaturedNeurosciencePsychology0 Comments 05 min read

This shows a person with pills in their hand

Common antidepressants interact with opioid med to lessen pain relief

Neuroscience NewsJune 25, 2019

SSRI antidepressants, such as Prozac and Paxil, interact with opioid medications to make them less effective at providing relief from chronic pain. Tramadol relies on activation of the CYP2D6 enzyme to control pain, but SSRIs inhibit this enzyme. Researchers suggest prescribing different classes of antidepressants which do not suppress the enzyme may benefit those in need of opioid medications. Alternatively, non-opioid pain killers should be considered for those who can not switch from SSRIs.... Read More...

FeaturedNeurologyNeuroscienceOpen Neuroscience ArticlesPsychology0 Comments 06 min read

Safe to breastfeed while on bipolar meds? Jury’s still out

Neuroscience NewsJune 10, 2019

Previous research into the effects of lithium exposure via breastmilk are poorly designed and sparse, researchers report. Until more research is done, mothers and babies should be reviewed on a case-by-case basis for lithium continuation, as discontinuing the medication could pose a significant risk for both child and parent.... Read More...

FeaturedNeurosciencePsychology0 Comments 05 min read

This shows a diagram of how the drug works

Diabetes drug alleviates anxiety in mice

Neuroscience NewsJune 3, 2019

Metformin, a common diabetes medication, shows promise for the treatment of anxiety and depression.... Read More...

FeaturedNeurosciencePsychology0 Comments 04 min read

This shows two heads with a psychedelic background

‘Ecstasy’ shows promise for post-traumatic stress treatment

Neuroscience NewsMay 30, 2019

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.... Read More...

FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology0 Comments 05 min read

News

Overdosing on psychedelics improved mental and physical health: Case studies

Our own immune cells damage the integrity of the blood-brain barrier

Why images may appear closer, or farther, than they actually are

Neuroscience

Overdosing on psychedelics improved mental and physical health: Case studies

Our own immune cells damage the integrity of the blood-brain barrier

Why images may appear closer, or farther, than they actually are

Neurology

Overdosing on psychedelics improved mental and physical health: Case studies

Eating a vegetarian diet rich in nuts, vegetables, soy linked to lower stroke risk

The Brain and Climate Change

AI

Learning difficulties due to poor connectivity, not specific brain regions

New study allows brain and artificial neurons to link up over the web

Artificial intelligence yields drug that halts antibiotic-resistant bacteria

Robotics

Surgeons successfully treat brain aneurysms using a robot

Baby’s Kicks Provide Clues About Infant Development

Low-cost “smart” diaper can notify caregiver when it’s wet

Psychology

Overdosing on psychedelics improved mental and physical health: Case studies

How sound and visual effects on slot machines increase the allure of gambling

Green space can reduce violent crime

neuropsychopharmacology

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

Could psychedelics help treat mental health and resolve the climate crisis?

New research confirms lingering mood benefit of psychedelics

Psychedelic drugs could help treat PTSD

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Common antidepressant may not reduce depression symptoms, but does reduce anxiety

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Ketamine isn’t an opioid and treats depression in a unique way

Common antidepressants interact with opioid med to lessen pain relief

Safe to breastfeed while on bipolar meds? Jury’s still out

Diabetes drug alleviates anxiety in mice

‘Ecstasy’ shows promise for post-traumatic stress treatment